Partnering & Outsourcing Editorial

1. 2 Expectations & 2 Warnings For The Year Ahead 12/19/2025

   Just when I thought I was done with 2026 predictions for the clinical trial industry, three members of my editorial board emailed me some great ones, hence, part 3 of this series. What’s interesting is that two of these submissions, coincidentally, are focused on optimism for AI. In contrast, Denise Bronner’s forecast for the coming year is much more … well, dire.

2. 2026 Forecasts From People Smarter Than Me – Part 1 12/12/2025

   In Part 1 of this forecast series, leaders from TransCelerate, Genentech, Clinical Performance Partners, Marketcap Consulting, and others weigh in on what’s coming next — from regulatory pressure and RBQM mandates to BYOT momentum, AI reality checks, and the financial rebound many CROs are betting on.

3. Heading For An M&A? Understand The Risks And Mitigation Strategies For Clinical Trial Agreements 11/10/2025

   Learn the key considerations to anticipate and mitigate risks that CTAs and diligence in the clinical trial space present during mergers and acquisitions (M&As).

4. The Rise Of Specialist CROs In Clinical Outsourcing 10/30/2025

   Understand the trends behind the growing specialist CRO sector.

5. We Need Communication Beyond The "Blah, Blah, Blah" 10/20/2025

   Miscommunication can derail clinical trials and lengthen study timelines. Discover how to improve communication among sponsors, CROs, and sites, and thus run more effective clinical trials.

6. Inside A Micro-CRO's Evolution 10/17/2025

   A new generation of micro-CROs is emerging—lean, virtual, and built by experienced ClinOps leaders. Instead of owning infrastructure, they’re renting it, showing that credibility and connections can rival size in today’s contract research market.

7. 100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing 10/17/2025

   Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.

8. How Skipping The CRO Helped RenovoRx Get Closer To Patients 9/24/2025

   RenovoRx Chief Clinical Officer Leesa Gentry explains why they decided to forgo a CRO partner.

9. 3 Ways Biotechs Can Relieve The Burden Of Their First Clinical Trial 9/23/2025

   Discover how non-profit partnerships, adaptive trial design, and real-world evidence can all play a part in helping biotech's successfully launch their first-in-human trial.

10. Running Global Clinical Trials? PolyPid Shares Operational And Regulatory Insights 8/11/2025

    PolyPid shares its clinical trial journey across the U.S., Europe, and Israel, highlighting operational complexities, regulatory navigation, and the adaptability required to execute large-scale, global studies.